Fund moves
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ILMN · NASDAQ · Life Sciences Tools & Services
Illumina, Inc. (ILMN) · oqro.io/stocks/ILMN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Illumina, Inc. was filed in the last 90 days. The latest on record was on Feb 11, 2026.
Since 2005, Illumina, Inc. insiders reported 33 open-market purchases and 7,165 sales on Forms 4 and 5, with purchases in 5 different years, most recently 2026.
In the last 90 days, 3 insiders of Illumina, Inc. (ILMN) reported 89 open-market sales worth $416M in total on SEC Form 4. The largest seller by value was Keith A. Meister, with $416M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Yes. Members of Congress disclosed 5 trades in Illumina, Inc. (ILMN) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Rep. Gilbert Ray Cisneros Jr. (CA31), Rep. Lisa C. McClain (MI09).
Illumina, Inc.'s next results are expected on Feb 3, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$210.01+7.40 (+3.65%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
+72.2% (+$88.04) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $121.97 on Nov 18, 2025 to $210.01 on Nov 18, 2026 (+72.2%). Disclosed in this range: 147 insider trades, 1 pre-arranged insider sale, 2 Congress trades, and 56 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Life Sciences Tools & Services company based in San Diego, California.
Last 12 months
+72.2%
Market value
$31.8B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 8.02M shares sold short (5.3% of shares outstanding), +1.7% vs the previous count, 3.7 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Illumina, Inc.: 1 fund cut or exited a position in the latest available 13F filings and 1 member of Congress disclosed sales. 2 of 3 tracked groups show selling activity. Based on public disclosures; it does not say why, or what happens next. Our test of this pattern
Revenue
$1.13B
+4.2% vs the same quarter a year earlier
Free cash flow, last 12 months
$1.06B
This quarter $379M, a year earlier $253M
Net debt
—
Debt —, cash $1.29B, at Sep 27, 2026
Backlog
$933M
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 29, 2026.
Revenue, fiscal 2025
$4.34B
−0.7% vs the year before
Net income, fiscal 2025
$850M
As reported in the annual filing
Shares outstanding
151M
As of Oct 23, 2026
In fiscal 2025 the company spent $742M buying back its own shares. Cash actually paid, from its cash-flow statement.
New federal contracts from the last 12 months add up to 0.14% of that revenue. Contract money is usually earned over several years, so this is a size comparison, not a share of sales.
Fund moves
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Traded Nov 9 – Nov 11, 2026 · largest single transaction ~$12.3MNot reported under a pre-arranged trading plan
Nov 9, 2026~$12.3M · 56K sh @ $220.80
DetailsOfficial recordNov 11, 2026~$5.81M · 27K sh @ $215.48
DetailsOfficial recordNov 9, 2026~$5.22M · 24K sh @ $221.70
DetailsOfficial recordPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Illumina, Inc. reported 33 open-market purchases and 7,165 sales since 2005; purchases in 5 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $24K1×1 trade | $720M145×145 trades |
| 2025 | $1.56M9×9 trades | $115K2×2 trades |
| 2024 | $992K3×3 trades | — |
| 2023 | — | $3.61M14×14 trades |
| 2022 | — | $3.25M19×19 trades |
| 2021 | — | $32.6M93×93 trades |
| 2020 | — | $51.3M173×173 trades |
| 2019 | — | $51.5M132×132 trades |
| 2018 | — | $59.7M193×193 trades |
| 2017 | — | $88.8M153×153 trades |
| 2016 | — | $50M138×138 trades |
| 2015 | — | $223M538×538 trades |
| 2014 | — | $215M526×526 trades |
| 2013 | — | $118M215×215 trades |
| 2012 | $47K3×3 trades | $8.23M25×25 trades |
| 2011 | $204K17×17 trades | $58.3M165×165 trades |
| 2010 | — | $65.2M203×203 trades |
| 2009 | — | $34M217×217 trades |
| 2008 | — | $52.3M1347×1,347 trades |
| 2007 | — | $40M1932×1,932 trades |
| 2006 | — | $14.6M934×934 trades |
| 2005 | — | $77K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Written by software from the filings listed below · Nov 13, 2026
4 more points, with the facts they come from, are in OQRO Pro.
Sign up freeFMR LLC
Schedule 13G: passive · filed Oct 7, 2026 · 16.2M shares
BlackRock, Inc.
Schedule 13G: passive · filed Oct 27, 2026 · 13.5M shares
Vanguard Capital Management
Schedule 13G: passive · filed Oct 30, 2026 · 11.4M shares
Capital World Investors
Schedule 13G: passive · filed Nov 13, 2026 · 10.1M shares
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
On the public record for Illumina, Inc. over the 12 months to Nov 18, 2026: 1 executive contribution and 5 WARN notices.
Against the S&P 500 over the year
Since Nov 14, 2025, ILMN is up 67.9% and the index fund is up 9.0%: 59 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much ILMN moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
Short sale volume: 45.2% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 58.8%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 16K shares (about $4.37M) were not delivered on time for settlement on Oct 16, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
A securities lawsuit naming the company as a defendant was filed on Dec 21, 2023 in the U.S. District Court, S.D. California. A filing is an allegation, not a finding.
Louisiana Sheriffs' Pension & Relief Fund v. Illumina, Inc., 3:23-cv-02328A securities lawsuit naming the company as a defendant was filed on Dec 21, 2023 in the U.S. District Court, S.D. California. A filing is an allegation, not a finding.
Roy v. Illumina, Inc., 3:23-cv-02327A securities lawsuit naming the company as a defendant was filed on Nov 10, 2023 in the U.S. District Court, S.D. California. A filing is an allegation, not a finding.
Kangas v. Illumina, Inc., 3:23-cv-02082Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
9 notices filed with state agencies, covering 63 workers in total. Employers must warn the state ahead of a plant closing or mass layoff at a site.
Official WARN lists from California, Texas, New York, Florida, Illinois and Washington only; notices filed in other states are not shown. Matched on the employer name as filed, so a notice filed under an unrelated subsidiary name can be missing. Dates are the notice date (Washington: the date the state received it).
34 certified in FY2026 Q3, vs 42 a year earlier. 34 positions in total, median offered wage $135K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Last results
Oct 29, 2026
Within the 30 days after it, until Nov 28, 2026
Next results, expected
Feb 3, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
100%
13 of 13 insider purchases since 2019 came within 30 days after a results announcement
From Illumina, Inc.'s own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Illumina, Inc.'s policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.